Michele Korfin
Directeur/Bestuurslid bij ORGANOGENESIS HOLDINGS INC.
Vermogen: 334 146 $ op 30-04-2024
Actieve functies van Michele Korfin
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ORGANOGENESIS HOLDINGS INC. | Directeur/Bestuurslid | 03-05-2022 | - |
Independent Dir/Board Member | 03-05-2022 | - | |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Directeur/Bestuurslid | - | - |
Bedrijfssecretaris | 13-02-2020 | - |
Loopbaan van Michele Korfin
Eerdere bekende functies van Michele Korfin
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
GAMIDA CELL LTD. | Operationeel Directeur | 01-08-2020 | 01-04-2024 |
TYME TECHNOLOGIES, INC. | Operationeel Directeur | 15-03-2019 | 01-01-2020 |
Corporate Officer/Principal | 15-10-2018 | 15-03-2019 | |
KITE PHARMA INC | Corporate Officer/Principal | 01-01-2016 | 01-07-2018 |
CELGENE | Corporate Officer/Principal | 01-01-2004 | 01-03-2016 |
Opleiding van Michele Korfin
Harvard Business School | Masters Business Admin |
Rutgers State University of New Jersey | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 8 |
Frankrijk | 2 |
Operationeel
Corporate Officer/Principal | 3 |
Chief Operating Officer | 2 |
Director/Board Member | 2 |
Sectoraal
Health Technology | 6 |
Consumer Services | 3 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
GAMIDA CELL LTD. | Health Technology |
ORGANOGENESIS HOLDINGS INC. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Tyme Technologies, Inc.
Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Tyme Technologies, Inc. operates as a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ. | Health Technology |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Commercial Services |
Kite Pharma, Inc.
Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Beurs
- Insiders
- Michele Korfin
- Ervaring